Skip to main content

Lobbying activity

Who's lobbying Congress, for whom, and on what, from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 3,985 filings

Top spenders & firms Spend by issue

Clear
Q1
WINNING STRATEGIES WASHINGTON for HOSPITAL ALLIANCE OF NEW JERSEY
1st Quarter (Jan 1 - Mar 31) 2026 · New Jersey · House · Senate · $10,000.00 income
Health Issues, Medicare/Medicaid, Budget/Appropriations
View →
Q1
WINNING STRATEGIES WASHINGTON for HEALTHCARE INSTITUTE OF NEW JERSEY
1st Quarter (Jan 1 - Mar 31) 2026 · New Jersey · House · Senate · $10,000.00 income
Health Issues
View →
Q1
CGCN GROUP, LLC for ALVOGEN, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · New Jersey · House · Senate · $60,000.00 income
Health Issues
View →
1T
WINNING STRATEGIES WASHINGTON for THE GOVERNOR'S PREVENTION PARTNERSHIP
1st Quarter (Jan 1 - Mar 31) 2026 · Connecticut · House · Senate
Health Issues
View →
Q1
WINNING STRATEGIES WASHINGTON for GIVE AN HOUR
1st Quarter (Jan 1 - Mar 31) 2026 · Maryland · House · Senate · $10,000.00 income
Defense, Health Issues
View →
Q1
WINNING STRATEGIES WASHINGTON for DR. LORNA BREEN HEROES FOUNDATION
1st Quarter (Jan 1 - Mar 31) 2026 · Virginia · House · Senate · $10,000.00 income
Health Issues, Budget/Appropriations
View →
Q1
WINNING STRATEGIES WASHINGTON for DIABETES PATIENT ADVOCACY COALITION
1st Quarter (Jan 1 - Mar 31) 2026 · Kentucky · House · Senate · $20,000.00 income
Health Issues, Medicare/Medicaid, Medical/Disease Research/Clinical Labs
View →
Q1
WINNING STRATEGIES WASHINGTON for DEBORAH HEART AND LUNG CENTER
1st Quarter (Jan 1 - Mar 31) 2026 · New Jersey · House · Senate · $20,000.00 income
Health Issues, Budget/Appropriations
View →
Q1
WINNING STRATEGIES WASHINGTON for DBV TECHNOLOGIES
1st Quarter (Jan 1 - Mar 31) 2026 · New Jersey · House · Senate · $30,000.00 income
Health Issues
View →
Q1
WINNING STRATEGIES WASHINGTON for CENTRASTATE HEALTHCARE SYSTEM
1st Quarter (Jan 1 - Mar 31) 2026 · New Jersey · House · Senate
Health Issues, Budget/Appropriations
View →
Q1
WINNING STRATEGIES WASHINGTON for ATLANTICARE
1st Quarter (Jan 1 - Mar 31) 2026 · New Jersey · House · Senate · $10,000.00 income
Health Issues, Budget/Appropriations
View →
Q1
WINNING STRATEGIES WASHINGTON for ACADEMY OF DOCTORS OF AUDIOLOGY
1st Quarter (Jan 1 - Mar 31) 2026 · Kentucky · House · Senate · $20,000.00 income
Health Issues, Medicare/Medicaid, Budget/Appropriations
View →
Q1
THE INGRAM GROUP LLC for BLUECROSS BLUESHIELD OF TENNESSEE, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · Tennessee · $20,000.00 income
Medicare/Medicaid, Health Issues
View →
Q1
FEROX STRATEGIES for WALMART INC.
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $60,000.00 income
Law Enforcement/Crime/Criminal Justice, Health Issues, Trade (domestic/foreign), Agriculture
View →
Q1
PFIZER INC. for PFIZER INC.
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate
Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid, Trade (domestic/foreign)
View →
Q1
FEROX STRATEGIES for SURGENEX
1st Quarter (Jan 1 - Mar 31) 2026 · Arizona · House · Senate · $50,000.00 income
Health Issues
View →
Q1
FEROX STRATEGIES for STOKE THERAPEUTICS
1st Quarter (Jan 1 - Mar 31) 2026 · Massachusetts · House · Senate · $40,000.00 income
Health Issues
View →
Q1
FEROX STRATEGIES for RARE DISEASE COMPANY COALITION
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $50,000.00 income
Taxation/Internal Revenue Code, Health Issues, Trade (domestic/foreign)
View →
Q1
FEROX STRATEGIES for PALANTIR TECHNOLOGIES, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate · $50,000.00 income
Defense, Health Issues, Homeland Security, Science/Technology
View →
Q1
ORCHARD THERAPEUTICS NORTH AMERICA for ORCHARD THERAPEUTICS NORTH AMERICA
1st Quarter (Jan 1 - Mar 31) 2026 · Massachusetts · House · Senate
Health Issues, Medicare/Medicaid
View →
Q1
FEROX STRATEGIES for NATIONAL RETAIL FEDERATION
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $30,000.00 income
Financial Institutions/Investments/Securities, Taxation/Internal Revenue Code, Law Enforcement/Crime/Criminal Justice, Consumer Issues/Safety/Products
View →
Q1
POINTCLICKCARE TECHNOLOGIES USA CORP. for POINTCLICKCARE TECHNOLOGIES USA CORP.
1st Quarter (Jan 1 - Mar 31) 2026 · Minnesota · House · Senate
Health Issues
View →
Q1
FEROX STRATEGIES for NATIONAL ELECTRICAL MANUFACTURERS ASSOCIATION (NEMA)
1st Quarter (Jan 1 - Mar 31) 2026 · Virginia · House · Senate · $50,000.00 income
Health Issues, Trade (domestic/foreign)
View →
Q1
FEROX STRATEGIES for FRESENIUS KABI USA LLC
1st Quarter (Jan 1 - Mar 31) 2026 · Illinois · House · Senate · $50,000.00 income
Health Issues, Pharmacy, Trade (domestic/foreign)
View →
Q1
FEROX STRATEGIES for DIAGEO NORTH AMERICA
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $50,000.00 income
Taxation/Internal Revenue Code, Health Issues
View →
Previous Page 100 of 160 Next

Source: federal Lobbying Disclosure Act filings. A filing's bill references are parsed from its activity descriptions, so a bill page shows the filings that named it.

Report a problem